{
    "Trade/Device Name(s)": [
        "IDS Cortisol"
    ],
    "Submitter Information": "Immunodiagnostic Systems Ltd.",
    "510(k) Number": "K202136",
    "Predicate Device Reference 510(k) Number(s)": [
        "K152227"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGR"
    ],
    "Summary Letter Date": "October 8, 2020",
    "Summary Letter Received Date": "October 13, 2020",
    "Submission Date": "27 July 2020",
    "Regulation Number(s)": [
        "21CFR862.1205"
    ],
    "Regulation Name(s)": [
        "Cortisol (Hydrocortisone And Hydroxycorticosterone) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Cortisol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum separator tube (SST)",
        "Lithium heparin tube",
        "Sodium heparin tube",
        "K2 EDTA tube",
        "K3 EDTA tube",
        "Red top serum tube (no additive)"
    ],
    "Instrument(s)/Platform(s)": [
        "IDS-iSYS Multi-Discipline Automated System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay"
    ],
    "Methodologies": [
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for IDS Cortisol chemiluminescence immunoassay for quantitative determination of cortisol in serum and plasma using IDS-iSYS system",
    "Indications for Use Summary": "Intended for quantitative determination of cortisol in human serum and plasma to assist clinicians in the diagnosis and treatment of disorders of the adrenal gland, used in conjunction with other clinical and laboratory data",
    "fda_folder": "Clinical Chemistry"
}